Ono Pharmaceutical Co., Ltd. (OPHLY)
5.09
-0.02
(-0.39%)
USD |
OTCM |
Aug 24, 16:00
Ono Pharmaceutical Total Liabilities (Quarterly) : 1.302B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.302B |
| March 31, 2026 | 1.571B |
| December 31, 2025 | 1.525B |
| September 30, 2025 | 1.669B |
| June 30, 2025 | 1.698B |
| March 31, 2025 | 1.845B |
| December 31, 2024 | 1.660B |
| September 30, 2024 | 1.806B |
| June 30, 2024 | 1.662B |
| March 31, 2024 | 760.27M |
| December 31, 2023 | 716.73M |
| September 30, 2023 | 754.77M |
| June 30, 2023 | 715.59M |
| March 31, 2023 | 1.012B |
| December 31, 2022 | 782.38M |
| September 30, 2022 | 653.78M |
| June 30, 2022 | 636.60M |
| March 31, 2022 | 638.76M |
| December 31, 2021 | 640.29M |
| September 30, 2021 | 835.33M |
| June 30, 2021 | 835.56M |
| March 31, 2021 | 956.42M |
| December 31, 2020 | 879.52M |
| September 30, 2020 | 911.56M |
| June 30, 2020 | 830.26M |
| Date | Value |
|---|---|
| March 31, 2020 | 976.54M |
| December 31, 2019 | 793.14M |
| September 30, 2019 | 806.62M |
| June 30, 2019 | 801.50M |
| March 31, 2019 | 834.08M |
| December 31, 2018 | 729.82M |
| September 30, 2018 | 617.63M |
| June 30, 2018 | 649.22M |
| March 31, 2018 | 748.55M |
| December 31, 2017 | 607.71M |
| September 30, 2017 | 615.88M |
| June 30, 2017 | 597.29M |
| March 31, 2017 | 836.85M |
| December 31, 2016 | 634.99M |
| September 30, 2016 | 663.67M |
| June 30, 2016 | 610.33M |
| March 31, 2016 | 571.16M |
| December 31, 2015 | 399.31M |
| September 30, 2015 | 389.64M |
| June 30, 2015 | 406.76M |
| March 31, 2015 | 411.72M |
| December 31, 2014 | 348.25M |
| September 30, 2014 | 284.99M |
| June 30, 2014 | 379.74M |
| March 31, 2014 | 329.82M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 49.87B |
| Daiichi Sankyo Co., Ltd. | 14.84B |
| Astellas Pharma, Inc. | 10.76B |
| Eisai Co., Ltd. | 3.845B |
| Chugai Pharmaceutical Co., Ltd. | 2.598B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.672B |
| Shareholders Equity (Quarterly) | 5.334B |
| Debt to Equity Ratio | 0.1351 |
| Current Ratio | 3.283 |
| Net Debt Paydown Yield | 0.76% |